Glorywin Entertainment Group, Inc. (GWIN)
OTCMKTS · Delayed Price · Currency is USD
0.5121
-0.4979 (-49.30%)
At close: Jul 27, 2026
GWIN Market Cap
GWIN has a market cap or net worth of $182.41 million as of August 31, 2026. Its market cap has increased by 175.32% in one year.
Market Cap
182.41M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.51
ChartMarket Cap Chart
Since October 31, 2016, GWIN's market cap has increased from 26.47M to 182.41M, an increase of 589.16%. That is a compound annual growth rate of 21.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 182.41M | 465.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 808.01M |
| Northwest Biotherapeutics | 323.39M |
| CytoDyn | 314.49M |
| Vaxart | 121.82M |
| HST Global | 91.93M |
| NDT Pharmaceuticals | 89.42M |
| Sangamo Therapeutics | 66.49M |
| Nuo Therapeutics | 53.28M |